Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2025 Earnings Call Transcript February 25, 2026
Operator: Good day, and thank you for standing by. Welcome to the Jazz Pharmaceuticals Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to turn the conference over to your speaker today, John Bluth, Head of Investor Relations. Please go ahead.
John Bluth: Thank you, and good afternoon, everyone. Today,...
